Abstract
The nonlinearity of cardiovascular regulation is higher in normal physiology, whereas several diseases are characterized by a reduction in this nonlinearity. Reduced nonlinearity of heart rate regulation is a robust risk factor for high mortality in patients with myocardial infarction. We investigated the changes in linear and nonlinear correlations of cardiovascular regulation after administering drugs in hypertensive diabetic rats. Type 1 diabetes was induced in rats by intraperitoneally injecting spontaneously hypertensive rats with streptozotocin. The animals were then divided into 4 groups and each group was given vehicle, candesartan, amlodipine, or insulin for 2 weeks. Blood pressure, heart rate, renal sympathetic nerve activity, and renal blood flow were simultaneously recorded in the conscious state, and the linear and nonlinear correlations were compared by using coherence and the mutual information method. Candesartan and amlodipine decreased blood pressure to a similar extent, but renal sympathetic nerve activity was significantly lower in the candesartan group than in the vehicle group. The renal sympathetic nerve activity in the insulin group was also lower than in the vehicle group. There were no significant differences in linear correlation among the 4 groups. In contrast, the nonlinear correlations between renal sympathetic nerve activity and blood pressure in the candesartan group and the insulin group were significantly higher than in the vehicle group. Candesartan and insulin decreased renal sympathetic nerve activity and increased the nonlinearity. These results suggest that reducing the activity of renin-angiotensin system and insulin that lowers blood glucose level may improve autonomic nervous system dysfunction and neurohumoral regulation of the cardiovascular system in diabetic hypertensive rats.
Similar content being viewed by others
Article PDF
References
Sytkowski PA, Kannel WB, D'Agostino RB : Changes in risk factors and the decline in mortality from cardiovascular disease; the Framingham Heart Study. N Engl J Med 1990; 23: 1635–1641.
Singh RB, Kartik C, Otuska K, Pella D, Pella J : Brain-heart connection and the risk of heart attack. Biomed Pharmacother 2002; 56 ( Suppl 2): 257–265.
Sakata K, Kumagai H, Osaka M, et al: Potentiated sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats. Circulation 2002; 106: 620–625.
Fraser AM, Swinney HL : Independent coordinates for strange attractors from mutual information. Phys Rev 1986; A33: 1134–1140.
Osaka M, Yambe T, Saitoh H, et al: Mutual information discloses relationship between hemodynamic variables in artificial heart-implanted dogs. Am J Physiol 1998; 275: H1419–H1433.
Yamamoto J : Blood pressure and metabolic effects of streptozotocin in Wistar-Kyoto and spontaneously hypertensive rats. Clin Exp Hypertens A 1998; 10: 1065–1083.
Dai S, Lee S, Battell M, McNeill JH : Cardiovascular and metabolic changes in spontaneously hypertensive rats following streptozotocin administration. Can J Cardiol 1994; 10: 562–570.
Nakamura K, Kishi K, Miyazawa A, Yagi S, Sokabe H : Antihypertensive treatment in spontaneously hypertensive rats with streptozotocin-induced diabetes mellitus. Acta Physiol Hung 1988; 71: 251–269.
Anderson E, Hoffman R, Balon T, Sinkey C, Mark A : Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246–2252.
Kumagai H, Suzuki H, Ichikawa M, et al: Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits. Circ Res 1993; 72: 1255–1265.
Kumagai H, Suzuki H, Ryuzaki M, Matsukawa S, Saruta T : Baroreflex control of renal sympathetic nerve activity is potentiated in early phase of two-kidney, one clip Goldblatt hypertension in conscious rabbits. Circ Res 1990; 67: 1309–1322.
Nishizawa M, Kumagai H, Ichikawa M, Oshima N, Suzuki H, Saruta T : Improvement in baroreflex function by an oral angiotensin receptor antagonist in rats with myocardial infarction. Hypertension 1997; 29: 458–463.
Berger RD, Akselrod S, Gordon D, Cohen RJ : An efficient algorithm for spectral analysis of heart rate variability. IEEE Trans Biomed Eng 1986; 33: 900–904.
Janssen BJA, Malpas SC, Burke SL, Head GA : Frequencydependent modulation of renal blood flow by renal nerve activity in conscious rabbits. Am J Physiol 1997; 273: R597–R608.
Bendat JS, Piersol AG : Random Data. Analysis and Measurement Procedures, 3rd ed. New York, John Wiley & Sons, 2000, pp 146–147.
Granger CB, McMurray JJV, Yusuf S, et al: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting–enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003; 362: 772–776.
Matsuura T, Kumagai H, Kawai A, et al: Rostral ventrolateral medulla neurons of neonatal Wistar-Kyoto and spontaneously hypertensive rats. Hypertension 2002; 40: 560–565.
Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M : Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR. J Hypertens 1999; 17: 917–922.
Yagi S, Morita T, Katayama S : Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress. Hypertens Res 2004; 27: 129–135.
Ono H, Minatoguchi S, Watanabe K, et al: Candesartan decreases carotid intima-media thickness by enhancing nitric oxide and decreasing oxidative stress in patients with hypertension. Hypertens Res 2008; 31: 271–279.
Srinivasan PS, Hakim ZS, Santani DD, Goyal RK : Effects of chronic treatment with amlodipine in streptozotocin-diabetic and spontaneously hypertensive rats. Pharmacol Res 1997; 35: 423–428.
Cooke JP, Dzau VJ : Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489–509.
Toba H, Nakagawa Y, Miki S, et al: Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the NG-nitro-L-arginine methyl ester–induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure–lowering effects of amlodipine and manidipine. Hypertens Res 2005; 28: 689–700.
Jimbo M, Suzuki H, Ichikawa M, et al: Role of nitric oxide in regulation of baroreceptor reflex. J Auton Nerv Syst 1994; 50: 209–219.
Tseng CJ, Liu HY, Lin HC, et al: Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 1996; 27: 36–42.
Babloyantz A, Destexhe A : Is the normal heart a periodic oscillator? Biol Cybern 1988; 58: 203–211.
Kobayashi M, Musha T : 1/f fluctuation of heartbeat period. IEEE Trans Biomed Eng 1982; 29: 456–457.
Wagner CD, Mrowka R, Nafz MA, Persson PB : Complexity and “chaos” in blood pressure after baroreceptor denervation of conscious dogs. Am J Physiol 1995; 269: H1760–H1766.
Goldberger AL : Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet 1996; 347: 1312–1314.
Skinner JE, Pratt CM, Vybiral T : A reduction in the correlation dimension of heartbeat intervals precedes imminent ventricular fibrillation in human subjects. Am Heart J 1993; 125: 731–743.
Osaka M, Saitoh H, Sasabe N, et al: Changes in autonomic activity preceding onset of nonsustained ventricular tachycardia. Ann Noninvasive Electrocardiol 1996; 1: 3–11.
Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M, DIAMOND Study Group: Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000; 101: 47–53.
Marsh DJ, Osborn JL, Cowley AW : 1/f fluctuation in arterial pressure and regulation of renal blood flow in dogs. Am J Physiol 1990; 258: F1394–F1400.
Oak JH, Cai H : Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes 2007; 56: 118–126.
Vollenmeider P, Tappy L, Randin D, et al: Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flows in humans. J Clin Invest 1993; 92: 147–154.
Gans ROB, Toorn VD, Bilo HJG, Nauta JJP, Heine RJ, Donker AJM : Renal and cardiovascular effects of exogenous insulin in healthy volunteers. Clin Sci 1991; 80: 219–225.
Sawicki PT, Baba T, Berger M, Starke A : Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance. J Am Soc Nephrol 1992; 3: S64–S68.
Vaz M, Jennings G, Turner A, Corx H, Lambert G, Esler M : Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96: 3423–3429.
Esler M, Straznicky N, Eikelis N, Masuo K, Lambert G, Lambert E : Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48: 787–796.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takimoto, C., Kumagai, H., Osaka, M. et al. Candesartan and Insulin Reduce Renal Sympathetic Nerve Activity in Hypertensive Type 1 Diabetic Rats. Hypertens Res 31, 1941–1951 (2008). https://doi.org/10.1291/hypres.31.1941
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1941